CWM
HRTX icon

CIBC World Markets’s Heron Therapeutics HRTX Stock Holding History

CIBC World Markets’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.2K Buy
+10,165
New +$12.6K ﹤0.01% 1231
2025
Q2 		$39K Sell
18,848
-7,202
-28% -$14.7K ﹤0.01% 1494
2025
Q1 		$57.3K Buy
26,050
+15,064
+137% +$29.2K ﹤0.01% 1695
2024
Q4 		$16.8K Buy
+10,986
New +$17.8K ﹤0.01% 1308

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

CIBC World Markets's HRTX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Heron Therapeutics (HRTX) in Q4 2025: 10,165 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #1231 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in HRTX as recently as Q2 2025.

CIBC World Markets first reported a position in HRTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $57.3K in Q1 2025. 170 funds tracked by Wall St. Rank hold HRTX as of Q4 2025.

  • CIBC World Markets held 10,165 shares of Heron Therapeutics worth $13.2K as of Q4 2025.
  • Heron Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Heron Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1231 holding.
  • CIBC World Markets first reported a position in Heron Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Heron Therapeutics position peaked at $57.3K in Q1 2025.
  • 170 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.